PubRank

Atle Fretheim

Author PubWeight™ 108.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of evidence in WHO recommendations. Lancet 2007 6.12
2 Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007 5.63
3 SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst 2009 3.93
4 The OFF theory of research utilization. J Clin Epidemiol 2005 3.79
5 SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst 2009 3.45
6 SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst 2009 3.34
7 SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking? Health Res Policy Syst 2009 3.32
8 Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst 2006 3.31
9 Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst 2006 2.93
10 Paying for performance to improve the delivery of health interventions in low- and middle-income countries . Cochrane Database Syst Rev 2012 2.49
11 Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. Health Res Policy Syst 2006 2.29
12 Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol 2008 2.28
13 Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst 2006 2.24
14 Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res 2012 2.16
15 SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst 2009 2.15
16 SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst 2009 2.05
17 SUPPORT Tools for evidence-informed health Policymaking (STP) 10: Taking equity into consideration when assessing the findings of a systematic review. Health Res Policy Syst 2009 2.03
18 SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst 2009 2.00
19 SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst 2009 1.99
20 Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J 2008 1.90
21 SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review. Health Res Policy Syst 2009 1.86
22 SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking. Health Res Policy Syst 2009 1.84
23 SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem. Health Res Policy Syst 2009 1.82
24 Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. Health Res Policy Syst 2007 1.81
25 Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst 2006 1.80
26 Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst 2006 1.80
27 Improving the use of research evidence in guideline development: 7. Deciding what evidence to include. Health Res Policy Syst 2006 1.67
28 Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Policy Syst 2006 1.66
29 Improving the use of research evidence in guideline development: 16. Evaluation. Health Res Policy Syst 2006 1.60
30 Can paying for results help to achieve the Millennium Development Goals? Overview of the effectiveness of results-based financing. J Evid Based Med 2009 1.56
31 SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking. Health Res Policy Syst 2009 1.54
32 Improving the use of research evidence in guideline development: 14. Reporting guidelines. Health Res Policy Syst 2006 1.51
33 Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity. Health Res Policy Syst 2006 1.46
34 [Thiazides (only) and hard endpoints]. Tidsskr Nor Laegeforen 2004 1.39
35 SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence. Health Res Policy Syst 2009 1.37
36 SUPPORT Tools for evidence-informed health Policymaking (STP) 12: Finding and using research evidence about resource use and costs. Health Res Policy Syst 2009 1.31
37 SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies. Health Res Policy Syst 2009 1.30
38 SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking. Health Res Policy Syst 2009 1.30
39 Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Policy Syst 2006 1.27
40 Can paying for results help to achieve the Millennium Development Goals? A critical review of selected evaluations of results-based financing. J Evid Based Med 2009 1.24
41 [Guidelines in general practice--are they read and are they used?]. Tidsskr Nor Laegeforen 2005 1.21
42 Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013 1.17
43 Performance-based financing in low- and middle-income countries: still more questions than answers. Bull World Health Organ 2012 1.16
44 The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial. PLoS Med 2009 1.09
45 The "Child Health Evidence Week" and GRADE grid may aid transparency in the deliberative process of guideline development. J Clin Epidemiol 2012 1.05
46 Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy 2012 0.88
47 Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study. PLoS One 2013 0.88
48 Use of evidence in WHO recommendations. World Hosp Health Serv 2007 0.86
49 A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One 2007 0.84
50 Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 2012 0.83
51 [How do general practice assistants keep themselves up to date?]. Tidsskr Nor Laegeforen 2005 0.81
52 How can research contribute to better global health? Tidsskr Nor Laegeforen 2011 0.79
53 The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial. PLoS One 2010 0.78
54 Barriers to skilled birth attendance: a survey among mothers in rural Gambia. Afr J Reprod Health 2014 0.78
55 [What do general practitioners do to keep themselves up to date?]. Tidsskr Nor Laegeforen 2005 0.77
56 [Documented good enough?]. Tidsskr Nor Laegeforen 2010 0.77
57 Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis. BMC Cardiovasc Disord 2012 0.76
58 VALUE: analysis of results. Lancet 2004 0.76
59 [Criticism of Norwegian screening study]. Tidsskr Nor Laegeforen 2008 0.75
60 [A. Fretheim replies]. Tidsskr Nor Laegeforen 2013 0.75
61 [Misleading about thiazides]. Tidsskr Nor Laegeforen 2004 0.75
62 Does bullying lead to health problems? Tidsskr Nor Laegeforen 2014 0.75
63 Current medical treatment for tuberculosis. More weight was given to observational studies than randomised controlled trials. BMJ 2003 0.75
64 [More and better evaluations in health care]. Tidsskr Nor Laegeforen 2009 0.75
65 [Thiazides in the treatment of hypertension]. Tidsskr Nor Laegeforen 2003 0.75
66 WITHDRAWN: Group based diabetes self-management education compared to routine treatment, waiting list control or no intervention for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2015 0.75
67 [Shortcomings and strength of practice guidelines]. Tidsskr Nor Laegeforen 2003 0.75
68 [Most help to the needest]. Tidsskr Nor Laegeforen 2005 0.75
69 [Drugs against the neglected diseases]. Tidsskr Nor Laegeforen 2002 0.75